How we help UCB
- Covid-era health policy developments
Throughout the pandemic the pharmaceutical and health industries have been in the spotlight, pulling together in response to an extraordinary and rapidly changing situation. As the NHS looks forward to system recovery, The Government’s white paper is critically important, with detail around operating plans, money flows and frameworks all impacting pharma. It’s a vast amount of information to sift through and absorb, which Rob needs to articulate back to the business, including medical, marketing, sales and field sales teams and help them to make sense of it. Specialist reports arriving from DeHavilland every morning make it possible
- Highly tailored email updates
DeHavilland’s team of experts focusing on the health and pharma arena compile tailored, timely email updates to keep UCB continuously abreast with stats, facts and figures, commentary and policy analysis. The updates are easy to absorb and detail what matters to UCB as a business.
- MP stakeholder management
DeHavilland’s unparalleled MP stakeholder database is intuitive and easy to use, enabling Rob to explore MPs’ interests, the groups they belong to and the relevant topics they tweet about.